GB201004739D0 - Receptor modulators - Google Patents
Receptor modulatorsInfo
- Publication number
- GB201004739D0 GB201004739D0 GBGB1004739.7A GB201004739A GB201004739D0 GB 201004739 D0 GB201004739 D0 GB 201004739D0 GB 201004739 A GB201004739 A GB 201004739A GB 201004739 D0 GB201004739 D0 GB 201004739D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- receptor modulators
- modulators
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1004739.7A GB201004739D0 (en) | 2010-03-22 | 2010-03-22 | Receptor modulators |
| PCT/EP2011/054374 WO2011117254A1 (en) | 2010-03-22 | 2011-03-22 | Piperidine amides as modulators of the ghrelin receptor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1004739.7A GB201004739D0 (en) | 2010-03-22 | 2010-03-22 | Receptor modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201004739D0 true GB201004739D0 (en) | 2010-05-05 |
Family
ID=42228098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1004739.7A Ceased GB201004739D0 (en) | 2010-03-22 | 2010-03-22 | Receptor modulators |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB201004739D0 (en) |
| WO (1) | WO2011117254A1 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012087630A1 (en) * | 2010-12-20 | 2012-06-28 | E.I. Du Pont De Nemours And Company | Pyridine and pyrimidine compounds for controlling invertebrate |
| EP2934584B1 (en) | 2012-12-21 | 2020-02-19 | Aveo Pharmaceuticals, Inc. | Anti-gdf15 antibodies |
| MX2016008688A (en) * | 2013-12-30 | 2017-01-12 | Lifesci Pharmaceuticals Inc | Therapeutic inhibitory compounds. |
| CN104496896B (en) * | 2014-05-21 | 2017-07-14 | 江西科技师范大学 | The preparation and application of the Sorafenib derivative of the urea structure containing sulphonyl |
| US10214508B2 (en) | 2014-06-13 | 2019-02-26 | Takeda Pharmaceutical Company Limited | Nitrogen-containing heterocyclic compound |
| ES2886641T3 (en) | 2014-08-11 | 2021-12-20 | Angion Biomedica Corp | Cytochrome P450 inhibitors and their uses |
| US10287282B2 (en) | 2014-12-31 | 2019-05-14 | Angion Biomedica Corp. | Methods and agents for treating disease |
| WO2016207345A1 (en) * | 2015-06-24 | 2016-12-29 | Pierre Fabre Medicament | 3-amino-pyrazin-2-yl carboxamide and 2-amino-pyridin-3-yl carboxamide derivatives as polo-like kinase 1 (plk-1) inhibitors for the treatment of cancer |
| CN107033015B (en) * | 2017-06-02 | 2019-04-30 | 南京欧信医药技术有限公司 | A kind of synthetic method of pharmaceutical intermediate |
| CN108863891B (en) * | 2018-08-01 | 2021-04-20 | 兰州石化职业技术学院 | Synthesis method of 1, 3, 4-triphenyl-1H-pyrrole-2, 5-diketone |
| AR117169A1 (en) * | 2018-11-28 | 2021-07-14 | Bayer Ag | (TIO) PYRIDAZINE AMIDES AS FUNGICIDE COMPOUNDS |
| JP2023527036A (en) | 2020-05-27 | 2023-06-26 | バイエル、アクチエンゲゼルシャフト | Combinations of active compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006012577A2 (en) * | 2004-07-22 | 2006-02-02 | Bayer Pharmaceuticals Corporation | Quinazolinone derivatives useful for the regulation of glucose homeostasis and food intake |
| GB0710865D0 (en) * | 2007-06-06 | 2007-07-18 | Glaxo Group Ltd | Novel compounds |
-
2010
- 2010-03-22 GB GBGB1004739.7A patent/GB201004739D0/en not_active Ceased
-
2011
- 2011-03-22 WO PCT/EP2011/054374 patent/WO2011117254A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011117254A1 (en) | 2011-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1232219A1 (en) | Sulfur derivatives as chemokine receptor modulators | |
| EP2791132A4 (en) | Estrogen receptor modulators and uses thereof | |
| PL2467380T3 (en) | Substituted benzoazepines as toll-like receptor modulators | |
| EP2467377A4 (en) | Substituted benzoazepines as toll-like receptor modulators | |
| IL218770A0 (en) | Novel modulators | |
| PL2663550T4 (en) | Substituted benzoazepines as toll-like receptor modulators | |
| EP2663555A4 (en) | Substituted benzoazepines as toll-like receptor modulators | |
| IL251897A0 (en) | Liver x receptor modulators | |
| IL227779A0 (en) | Cannabinoid receptor modulators | |
| GB201004739D0 (en) | Receptor modulators | |
| EP2531029A4 (en) | Selective androgen receptor modulators | |
| EP2624697A4 (en) | Dihydrobenzoquinazolinone m1 receptor positive allosteric modulators | |
| HK1206333A1 (en) | Liver receptor modulators | |
| ZA201303950B (en) | Glucagon receptor modulators | |
| IL235557A0 (en) | Gpr17 receptor modulators | |
| PL2400207T3 (en) | Fixing device | |
| EP2566494A4 (en) | Cxcr4 receptor compounds | |
| GB201016346D0 (en) | Connection means | |
| IL220839A0 (en) | Nicotinic acetylcholine receptor modulators | |
| GB201009303D0 (en) | Fixing device | |
| GB201008732D0 (en) | Over fill improvements |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |